Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model

Jianqing Lin; Deqiang Fu; Yijun Dai; Jianguang Lin; Tianwen Xu

doi:10.18632/oncotarget.18772

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model

Jianqing Lin, Deqiang Fu, Yijun Dai, Jianguang Lin and Tianwen Xu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:114457-114462. https://doi.org/10.18632/oncotarget.18772

Metrics: PDF 1729 views | HTML 2292 views | ?

Abstract

Jianqing Lin1, Deqiang Fu1, Yijun Dai1, Jianguang Lin1 and Tianwen Xu1

1Department of Medical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China

Correspondence to:

Tianwen Xu, email: [email protected]

Keywords: ESCC, Mcl-1, A-1210477

Received: January 10, 2017 Accepted: March 21, 2017 Published: June 28, 2017

ABSTRACT

Esophageal squamous cell carcinoma (ESCC) has a high morbidity in China, accounting for 90% of all esophageal carcinoma cases. Hence, identifying drug targets for prevention and treatment of ESCC is essential. Due to its critical role in the regulation of cell apoptosis, Mcl-1 holds great potential as a target for treatment against ESCC. In current study, we used a 4-nitroquinoline-1-oxide (4-NQO)-induced ESCC mouse model of test whether A-1210477, a Mcl-1 small molecular inhibitor, could repress ESCC development. We showed that A-1210477 treatment decreased ESCC formation and animal weight loss in a dose dependent manner. We detected decreased cellular proliferation in A-1210477-treated ESCC tissue by Ki67 expression. Moreover, A-1210477 treatment increased the number of apoptotic cells in ESCC tissues. Our study clearly demonstrates the contribution of Mcl-1 to ESCC development through promoting cell proliferation and inhibition of apoptosis, and provides a strong evidence for further evaluation of A-1210477 for treating ESCC.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18772

Publication Alerts

Research Papers:

Mcl-1 inhibitor suppresses tumor growth of esophageal squamous cell carcinoma in a mouse model

Abstract